Market closed
Neuronetics/$STIM
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Neuronetics
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.
Ticker
$STIM
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
716
Website
Neuronetics Metrics
BasicAdvanced
$237M
-
-$1.38
1.98
-
Price and volume
Market cap
$237M
Beta
1.98
52-week high
$5.92
52-week low
$3.40
Financial strength
Current ratio
1.859
Quick ratio
1.344
Long term debt to equity
244.778
Total debt to equity
259.845
Interest coverage (TTM)
-4.74%
Management effectiveness
Return on assets (TTM)
-17.07%
Return on equity (TTM)
-148.19%
Valuation
Price to revenue (TTM)
1.525
Price to book
7.23
Price to tangible book (TTM)
-19.03
Price to free cash flow (TTM)
-3.519
Growth
Revenue change (TTM)
4.96%
Earnings per share change (TTM)
29.68%
3-year revenue growth (CAGR)
10.63%
3-year earnings per share growth (CAGR)
3.72%
Neuronetics News
AllArticlesVideos
Evernorth Health Services, a Cigna Company, Expands NeuroStar® TMS Coverage for Adolescents Struggling with Depression
GlobeNewsWire·5 days ago
Neuronetics: Explosive Growth Poised To Soar On FDA Breakthroughs
Seeking Alpha·6 days ago
Neuronetics Reports Updated Fourth Quarter and Full Year 2024 Financial and Operating Results
GlobeNewsWire·1 week ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Neuronetics stock?
Neuronetics (STIM) has a market cap of $237M as of April 05, 2025.
What is the P/E ratio for Neuronetics stock?
The price to earnings (P/E) ratio for Neuronetics (STIM) stock is 0 as of April 05, 2025.
Does Neuronetics stock pay dividends?
No, Neuronetics (STIM) stock does not pay dividends to its shareholders as of April 05, 2025.
When is the next Neuronetics dividend payment date?
Neuronetics (STIM) stock does not pay dividends to its shareholders.
What is the beta indicator for Neuronetics?
Neuronetics (STIM) has a beta rating of 1.98. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.